Cite
Infliximab and adalimumab for uveitis.
MLA
Martel JN, et al. “Infliximab and Adalimumab for Uveitis.” Ocular Immunology & Inflammation, vol. 20, no. 1, Feb. 2012, pp. 18–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104518476&authtype=sso&custid=ns315887.
APA
Martel JN, Esterberg E, Nagpal A, & Acharya NR. (2012). Infliximab and adalimumab for uveitis. Ocular Immunology & Inflammation, 20(1), 18–26.
Chicago
Martel JN, Esterberg E, Nagpal A, and Acharya NR. 2012. “Infliximab and Adalimumab for Uveitis.” Ocular Immunology & Inflammation 20 (1): 18–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104518476&authtype=sso&custid=ns315887.